China Universal Asset Management Company’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$309K Sell
800
-450
-36% -$167K 0.02% 316
2026
Q1
$366K Sell
1,250
-750
-38% -$246K 0.03% 291
2025
Q4
$701K Sell
2,000
-1,000
-33% -$338K 0.05% 221
2025
Q3
$969K Sell
3,000
-600
-17% -$187K 0.08% 182
2025
Q2
$1.4M Sell
3,600
-703
-16% -$283K 0.13% 134
2025
Q1
$1.87M Buy
4,303
+1,197
+39% +$481K 0.17% 114
2024
Q4
$1.15M Buy
+3,106
New +$1.3M 0.11% 145

Other funds holding ELV

China Universal Asset Management Company's ELV Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Elevance Health (ELV) stake by 36% in Q2 2026, selling an estimated $167K and leaving 800 shares worth $309K. The position accounts for 0.02% of the portfolio, ranked #316.

China Universal Asset Management Company first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.87M in Q1 2025. 1,149 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • China Universal Asset Management Company held 800 shares of Elevance Health worth $309K as of Q2 2026.
  • China Universal Asset Management Company sold 450 Elevance Health shares in Q2 2026, an estimated $167K.
  • Elevance Health made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #316 holding.
  • China Universal Asset Management Company first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • China Universal Asset Management Company's Elevance Health position peaked at $1.87M in Q1 2025.
  • 1,149 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.